RxNorm Names
SENNA LAXATIVE NATURAL VEGETABLE LAXATIVE
(sennosides)
tablet
[SuperValu (Equaline)]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f00c8326-26de-4af9-bf1a-13021e0737ac| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph not final |
Uses
- relieves occasional constipation (irregularity)
- generally produces a bowel movement within 6- 12 hours.
Warnings
Do not use
- laxative products for longer than 1 week unless directed by a doctor.
Ask a doctor before using if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that continues over a period of 2 weeks.
Directions
- take preferably at bedtime or as directed by a doctor
|
age | starting dosage | maximum dosage |
| adults and children over 12 years of age or older | 2 tablets once a day | 4 tablets twice a day |
| children 6 to under 12 years | 1 tablet once a day | 2 tablets twice a day |
| children 2 to under 6 years | 1/2 tablet once a day | 1 tablet twice a day |
| children under 2 years | ask a doctor | ask a doctor |
Other information
- each tablet contains: calcium 25 mg
- store at 25o C (77o F); excursions permitted between 15o - 30o C (59o- 86o F)
Inactive Ingredients
croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, liquid paraffin*, magnesium stearate, maltodextrin*, microcrystalline cellulose, mineral oil*, silicon dioxide*, stearic acid*, sodium lauryl sulfate*, talc*, triacetin*
*contains one or more of these ingredients
Principal Display Panel
Compare senokot® active ingredient **
Senna Laxative
Natural vegetable laxative
Sennosides 8.6 mg each
gentle relief of occasional constipation
overnight gentle relief
**This product is not manufactured or distributed by Purdue Pharma L.P., owner of the registered trademark Senokot®
KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION
DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
| SENNA LAXATIVE
NATURAL VEGETABLE LAXATIVE
sennosides tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - SuperValu (Equaline) (006961411) |
| Registrant - P and L Development of New York Corporation (800014821) |
Review RxNorm Normal Forms